This funding opportunity supports research focused on discovering and developing interventions to prevent and treat substance use disorders and overdose. It includes studies on medications and medical devices for co-morbid SUDs, emphasizing high-impact preclinical and clinical research that advances candidate interventions toward regulatory approval or clinical adoption. The UG3/UH3 activity code is utilized for this grant.
Eligible applicants include a wide range of organizations such as county and state governments, tribal governments, institutions of higher education, nonprofits, small businesses, and federal agencies. Both domestic and certain non-domestic entities may apply.
